Sorrento Therapeutics Could Have a COVID-19 Cure: Is the Stock a Buy?
You've no doubt heard plenty in the news about the scramble to develop vaccines for the novel coronavirus disease, COVID-19. And you've probably heard about drugs that could potentially be used to help treat some COVID-19 patients. But you may not have heard much about therapies that -- rather than just treating COVID-19 -- hold the potential to cure the disease.
Sorrento Therapeutics (NASDAQ: SRNE) thinks it has a therapy that could cure COVID-19. Actually, it could have at least two potential COVID-19 cures. With these possibly game-changing therapies in Sorrento's pipeline, is the biotech stock a slam-dunk buy right now?
Image source: Getty Images.
Source Fool.com
